The Effect of Eating Pulses for 8 Weeks on Satiety and Metabolic Syndrome Risk Factors in Overweight Individuals
NCT ID: NCT00604448
Last Updated: 2012-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2008-02-29
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Meta-analyses of the Effect of Dietary Pulses on Acute Postprandial Metabolic Control
NCT01605422
Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight
NCT00741923
Meta-analyses of Dietary Pulses and Cardiometabolic Risk
NCT01594567
Food Structure of Pulses and Satiety
NCT04922125
Impacts of Lentils on Metabolism and Inflammation
NCT04283448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The amount of pulses to be included in the study protocol is based on the USDA Dietary Guideline of 3 cups of pulses per week, but is somewhat high at 5 cups/week. Both groups will receive counseling from a registered dietitian. Pulses will be provided free of charge, delivered weekly to each participant and instructions will be given on their preparation. Subjects will be asked to complete a pulse log to record the date and time of day the pulses are consumed, as well as the type of pulse and other foods consumed during the pulse meal. Cooked pulses will be provided in canned or frozen forms. After completing the meal, subjects will be asked to fill out information (ID, date and time) on the sealed sticker attached to each can or inserted into the frozen pulses portion. In order to measure compliance, subjects will be asked to return all stickers at the end of the week, when new foods are provided to them. For those in the energy restriction group, the dietitian will a have a defined amount of time to advise on how to reduce caloric intake by 500 kcal per day at week 1 (the start of the study) and week 4 (halfway through the study). In addition, the dietitian will obtain a food history and ask additional pulse consumption questions at week 1 and week 8. Also, a 24 h food recall will be obtained from subjects by a dietitian at weeks 1, 4 and 8.
For all subjects, body weight, waist girth, blood pressure, fasting blood lipids, glucose, insulin and satiety hormones will be measured at weeks 1, 4 and 8. Each subject will arrive at the same chosen time for each session, between 8:00 and 10:00 a.m. Upon arrival, subjects will fill out a Sleep Habits and Stress Factors Questionnaire and a Food Intake and Activity Questionnaire. For each session, subjects will be asked to arrive after an overnight fast; only water will be allowed until 1 hour before blood collection.
Blood glucose and insulin response to a glucose load (75 g) will be determined at weeks 1 and 8. For this test (an oral glucose tolerance test), an indwelling catheter will be inserted in the antecubital vein by a nurse and blood samples will be taken at prior to (-15 minutes) and at 0, 10, 20, 30, 60, 90 and 120 minutes after the consumption of a 75 g glucose drink. A total of 90 ml of blood will be sampled at weeks 1 and 8. A single fasting blood sample (20 ml of blood) will also be obtained at week 4 for the same analysis. The week 1 and week 8 sessions will last a maximum of 4 hours and the week 4 session will last a maximum of 2 hours.
Blood samples will be analyzed for glucose, insulin, leptin, ghrelin, glucagon-like peptide-1 (GLP-1), low-density lipoprotein (LDL), triglyceride (TG), C-reactive protein, C-peptide, adiponectin and glycosylated hemoglobin (HbA1c).
Pulses will be obtained from Can Grow Foods, Heinz or purchased from the supermarket.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulse group
a group receiving a meal with pulses (5 cups/week) for 8 weeks
Dietary advise
Subjects in energy-restricted group will follow dietician advise to keep a conventional energy restriction diet.
Diet enriched with a meal containing pulses
Subjects in pulse group will consume the commercially available pulses for 8 weeks
Energy-restricted group
a group with a diet restriction of 500 kcal/day for 8 weeks
Dietary advise
Subjects in energy-restricted group will follow dietician advise to keep a conventional energy restriction diet.
Diet enriched with a meal containing pulses
Subjects in pulse group will consume the commercially available pulses for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary advise
Subjects in energy-restricted group will follow dietician advise to keep a conventional energy restriction diet.
Diet enriched with a meal containing pulses
Subjects in pulse group will consume the commercially available pulses for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index: 27-35 kg/m2
* individuals not prescribed medications over the past 6 months that could interfere with the study outcomes (i.e. statins or metformin)
Exclusion Criteria
* those on an energy restricted diet
* breakfast skippers
* pregnant/lactating women
35 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mount Sinai Hospital, Canada
OTHER
University of Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
G. Harvey Anderson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harvey G. Anderson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leadership Sinai Centre for Diabetes, Mt. Sinai Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UfT fund#: 481556
Identifier Type: -
Identifier Source: secondary_id
Pulse_Canada_481556
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.